DIAGNOSTICS FOR THE REAL WORLD
DIAGNOSTICS FOR THE REAL WORLD LTD [DRW] was founded by
Dr Helen Lee in 2002 in order to make more widely available breakthrough technologies developed by her group at the Diagnostics Development Unit [DDU] at the University of Cambridge.
DRW's mission is to develop cutting-edge technologies and diagnostic assays for deployment in resource poor countries primarily through patient sample testing at the point of care or near the patient. Avoiding both the unreliability of previous simple point-of-care technologies and the prohibitive costs and logistical difficulties associated with central laboratory testing, DRW's SAS and SAMBA assays provide a fast, accurate and cost-effective method for testing and diagnosis when and where it is most needed.
These technologies can deliver outstandingly reliable Whole Blood Qualitative test for Early Infant and Acute Infection Diagnosis as well as full Roche TaqMan v2 concordance for Plasma Semi-Quantitative and Whole Blood Semi-Quantitative tests when monitoring viral load.
DRW is based in San Jose, California and in Cambridge, United Kingdom.